Find participating medical centers and current study status in each of them

    Find participating medical centers

    A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases

    • Cancer
    • Skin Cancer
    • Wild Type Melanoma
    • Melanoma
    • Metastatic Melanoma

    For the latest version of this information please go to www.forpatients.roche.com